maybe dongfang kept their IPO money in Australia and did not transfer it back to China in the first instance. Perhaps, we could consider selling the subsidiary in Hong Kong and return money to shareholders.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025